Adalimumab for nail psoriasis: Efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial
Journal of the European Academy of Dermatology and Venereology | Oct 09, 2019
Tattoo complications in treated and non-treated psoriatic patients
Journal of the European Academy of Dermatology and Venereology | Oct 04, 2019
Linkage between patients’ characteristics and prescribed systemic treatments for Psoriasis: A semantic connectivity map analysis of the Swiss SDNTT registry
Journal of the European Academy of Dermatology and Venereology | Oct 03, 2019
Secukinumab is effective in treatment of moderate to severe plaque psoriasis: Real-life effectiveness and safety from the PROSPECT study
Journal of the European Academy of Dermatology and Venereology | Sep 29, 2019